text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

c-Jun N-terminal kinase (JNK) Inhibitor: SU 3327

No.178(July 2018)
A2940
SU 3327 (1)
SU 3327 (1) is a JNK (c-Jun N-terminal kinase) inhibitor developed based on structure-activity relationship studies.1) 1 inhibits activating transcription factor-2 (AFT-2) phosphorylation by JNK1 with IC50 = 0.7 μM in a substrate competitive manner. 1 also inhibits protein-protein interaction between JNK and JIP-1* with IC50 = 239 nM.
As one of the important roles JNK plays in the induction of autophagy via stimulations as shown in Table 1. It has been demonstrated that acute ethanol treatment decreased autophagy in mouse models and the decrease in autophagy was prevented by 1.2)
* JIP-1: JNK-interacting proteins (JIP) were identified as JNK scaffold proteins.3,4) JIP1 is a member of the JIP family and contains a JNK binding domain (JBD), a SRC homology (SH3) domain, and phosphotyrosine-binding (PTB) domain. JBD possesses the consensus sequence, R/KXXXXLXL.5) The probe, pep-JIP1, used in the reference (1), contains the sequence.

Table 1. Autophagy by various stimuli implicating JNK

These products are for research purpose only.

References

The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
세션 상태
세션의 남은 시간은 10분입니다. 이대로 방치하면 세션이 끊어지고 탑페이지로 돌아갑니다. 같은 페이지에서 세션을 계속하려면 버튼을 클릭하십시오.분입니다. 이대로 방치하면 세션이 끊어지고 탑페이지로 돌아갑니다. 같은 페이지에서 세션을 계속하려면 버튼을 클릭하십시오.

세션이 시간 초과되었습니다. 탑페이지로 돌아갑니다.